UPDATE : Monday, June 18, 2018
상단여백
How are Korean drugmakers performing in China? by So Jae-hyeon 2018-04-17 15:12
Handok to sell Astellas’ diabetes therapy by Marian Chu 2018-04-17 13:52
GemVax & KAEL gets positive P2 data on GV1001 for prostate hyperplasia by Marian Chu 2018-04-16 16:50
Humedix eyes global entry with skin-regenerating injection by Marian Chu 2018-04-16 14:47
Will anti-smoking drug Champix still be champion? by So Jae-hyeon 2018-04-16 14:46
라인
Janssen Korea launches new psoriasis treatment by Lee Hye-seon 2018-04-16 11:48
GE Healthcare Korea launches ₩2.5-bil. program to foster biotech by Marian Chu 2018-04-16 11:45
Roche Korea’s Alecensa gets approval as 1st line lung cancer therapy by Marian Chu 2018-04-13 16:46
SillaJen reveals clinical results on Pexa-Vec in UK by So Jae-hyeon 2018-04-13 16:38
Hanmi gives up on lung cancer drug Olita by Lee Hye-seon 2018-04-13 11:00
라인
LG Chem works on 3-in-1 combo for hypertension by Lee Hye-seon 2018-04-12 16:32
Obesity drug Saxenda’s sheds ‘1-year effect’ stigma by Nam Doo-hyun 2018-04-11 14:11
YD Life Science preps diabetes complication therapy for global launch by Marian Chu 2018-04-10 17:36
JW Pharm discovers novel H4R antagonist for atopic dermatitis by Marian Chu 2018-04-10 17:36
Janssen Korea gets reimbursement for leukemia drug by Marian Chu 2018-04-10 16:14
라인
LG Chem, Merck to co-market hypertension drug by So Jae-hyeon 2018-04-10 15:15
Il-yang’s ‘Supect’ loses 2nd indication for leukemia by Lee Hye-seon 2018-04-10 15:14
Tamiflu crushed generic copies in flu season by So Jae-hyeon 2018-04-09 15:40
Biosimilars take on original at breast cancer conference by So Jae-hyeon 2018-04-09 15:05
Boehringer Ingelheim Korea CEO was forced to resign? by Nam Doo-hyun 2018-04-06 16:10
여백
여백
여백
Back to Top